1
Quist, S. W., Paulissen, J. H.J., Wyndaele, D. N.J., Nagarajah, J., Freriks, R. D.
Veröffentlicht in: Quist , S W , Paulissen , J H J , Wyndaele , D N J , Nagarajah , J & Freriks , R D 2023 , ' Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I &T for metastatic castration-resistant prostate cancer in Dutch hospitals ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 366-375 . https://doi.org/10.1080/13696998.2023.2183618;
2023
Veröffentlicht in: Quist , S W , Paulissen , J H J , Wyndaele , D N J , Nagarajah , J & Freriks , R D 2023 , ' Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I &T for metastatic castration-resistant prostate cancer in Dutch hospitals ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 366-375 . https://doi.org/10.1080/13696998.2023.2183618;
2023
2
Quist, S. W., Postma, A. J., Myrén, K. J., de Jong, L. A., Postma, M. J.
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
3